| Literature DB >> 23734170 |
Seyed Mohsen Mousavi1, Asta Försti, Kristina Sundquist, Kari Hemminki.
Abstract
BACKGROUNDS: The clinical tumor-node-metastasis (T, N and M) classes of breast cancers provide important prognostic information. However, the possible association of TNM classes with reproductive factors has remained largely unexplored. Because every woman has a reproductive history, implications to outcome prediction are potentially significant.Entities:
Mesh:
Year: 2013 PMID: 23734170 PMCID: PMC3667089 DOI: 10.1371/journal.pone.0058867
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Odds ratios (ORs) for TNM classes in postmenopausal breast cancer by reproductive factors.
| Reproductive factors | T1 | Tis | T2–T4 | N0 | N1–N3 vr. N0 | M0 | M1 vr. M0 | ||||||||
| N | N | OR (95%CI) | P | N | OR (95%CI) | P | N | N | OR (95%CI) | P | N | N | OR (95%CI) | P | |
|
| |||||||||||||||
| 1 (Ref.) | 1,924 | 39 | 1.00 | 1,620 | 1.00 | 2,546 | 1,005 | 1.00 | 2,862 | 145 | 1.00 | ||||
| 0 | 1,114 | 26 | 1.16 (0.70–1.93) | 0.57 | 816 | 1.08 (0.96–1.21) | 0.21 | 1,527 | 552 | 0.97 (0.85–1.09) | 0.58 | 1,638 | 55 | 0.90 (0.65–1.24) | 0.51 |
| 2 | 4,806 | 107 | 1.16 (0.80–1.68) | 0.44 | 3,043 |
| <0.0001 | 6,030 | 2,160 | 0.91 (0.84–1.00) | 0.05 | 6,572 | 199 |
| <0.01 |
| 3 | 2,185 | 50 | 1.19 (0.78–1.82) | 0.43 | 1,457 |
| <0.01 | 2,676 | 1,070 | 0.99 (0.90–1.10) | 0.87 | 2,943 | 100 |
| 0.01 |
| ≥4 | 765 | 12 | 0.79 (0.41–1.52) | 0.47 | 687 | 0.98 (0.86–1.11) | 0.73 | 988 | 435 | 1.03 (0.90-1.18) | 0.68 | 1,171 | 49 |
| 0.04 |
| Total | 10,794 | 234 | 7,623 | 13,767 | 5,222 | 15,186 | 548 | ||||||||
Bold type: 95% CI does not include 1.00. The ORs were adjusted for:
1. Age at diagnosis, region, and occupation.
2. Age at diagnosis, region, occupation, and parity.
Carcinoma in situ.
The number of cases for T2 (N = 6,098), T3 (871), and T4 (654).
Odds ratios (ORs) for TNM classes in postmenopausal breast cancer by age at first and last childbirth, stratified by time interval between first and last childbirth.
| Age at breast cancer diagnosis | T1 | Tis | T2–T4 | N0 | N1–N3 vr. N0 | M0 | M1 vr. M0 | ||||||||
| N | N | OR (95%CI) | P | N | OR (95%CI) | P | N | N | OR (95%CI) | P | N | N | OR (95%CI) | P | |
|
| |||||||||||||||
| 20-29 (Ref.) | 2,574 | 55 | 1.00 | 1,503 | 1.00 | 2,607 | 1,145 | 1.00 | 2,863 | 75 | 1.00 | ||||
| ≤19 | 277 | 5 | 0.84 (0.33–2.13) | 0.71 | 138 | 0.08 (0.71–1.10) | 0.25 | 20 | 132 | 1.14 (0.92–1.42) | 0.24 | 23 | 5 | 0.63 (0.25–1.58) | 0.33 |
| 30–39 | 569 | 13 | 1.00 (0.54–1.87) | 1.00 | 415 | 1.14 (0.99-1.32) | 0.09 | 1,574 | 252 | 0.90 (0.77–1.06) | 0.21 | 1,679 | 31 |
| 0.03 |
| ≥40 | 9 | 0 | 12 | 2.22 (0.91–5.40) | 0.08 | 58 | 7 | 1.79 (0.70–4.58) | 0.23 | 75 | 1 | 2.96 (0.37–23.62) | 0.31 | ||
| Total | 3,429 | 73 | 2,068 | 1,574 | 1,536 | 4,640 | 112 | ||||||||
Bold type: 95% CI does not include 1.00.
Women with two or more children were included. ORs were adjusted for parity, region and occupation.
Carcinoma in situ.
Odds ratios (ORs) for TNM classes in postmenopausal ductal carcinoma by reproductive factors.
| Reproductive factors | T1 | Tis | T2–T4 | N0 | N1–N3 vr. N0 | M0 | M1 vr. M0 | ||||||||
| N | N | OR (95%CI) | P | N | OR (95%CI) | P | N | N | OR (95%CI) | P | N | N | OR (95%CI) | P | |
|
| |||||||||||||||
| 1 (Ref.) | 1,399 | 22 | 1.00 | 1,033 | 1.00 | 1,746 | 717 | 1.00 | 1,979 | 72 | 1.00 | ||||
| 0 | 830 | 20 | 1.54 (0.83–2.87) | 0.17 | 553 | 1.08 (0.95–1.25) | 0.25 | 1,115 | 402 | 0.92 (0.80–1.07) | 0.29 | 1,211 | 30 | 0.90 (0.58–1.41) | 0.65 |
| 2 | 3,519 | 71 | 1.32 (0.82–2.15) | 0.26 | 2,004 |
| <0.01 | 4,247 | 1606 | 0.93 (0.84–1.03) | 0.17 | 4,699 | 105 |
| 0.01 |
| 3 | 1,599 | 31 | 1.31 (0.75–2.28) | 0.34 | 958 |
| <0.01 | 1,871 | 784 | 1.00 (0.89–1.13) | 0.95 | 2,083 | 55 | 0.74 (0.52–1.06) | 0.10 |
| ≥4 | 534 | 7 | 0.92 (0.39–2.18) | 0.85 | 440 | 1.03 (0.88–1.20) | 0.73 | 669 | 307 | 1.03 (0.88–1.21) | 0.73 | 799 | 30 | 0.84 (0.54–1.30) | 0.44 |
| Total | 7,881 | 151 | 4,988 | 9,648 | 3,816 | 10,771 | 292 | ||||||||
Bold type: 95% CI does not include 1.00. The ORs were adjusted for:
1. Age at diagnosis, region, and occupation.
2. Age at diagnosis, region, occupation, and parity.
Carcinoma in situ.
The number of cases for T2 (N = 4,133), T3 (484), and T4 (371).
Odds ratios (ORs) for TNM classes in postmenopausal lobular carcinoma by reproductive factors.
| Reproductive factors | T1 | Tis | T2–T4 | N0 | N1–N3 vr. N0 | M0 | M1 vr. M0 | ||||||||
| N | N | OR (95%CI) | P | N | OR (95%CI) | P | N | N | OR (95%CI) | P | N | N | OR (95%CI) | P | |
|
| |||||||||||||||
| 1 (Ref.) | 246 | 3 | 1.00 | 303 | 1.00 | 404 | 164 | 1.00 | 459 | 19 | 1.00 | ||||
| 0 | 146 | 2 | 1.04 (0.17–6.49) | 0.96 | 152 | 0.95 (0.72–1.27) | 0.75 | 216 | 82 | 0.98 (0.71–1.35) | 0.91 | 229 | 6 | 0.74 (0.29–1.92) | 0.54 |
| 2 | 618 | 11 | 1.61 (0.44–5.93) | 0.47 | 555 |
| 0.01 | 858 | 320 | 0.90 (0.72–1.13) | 0.37 | 950 | 28 | 0.75 (0.41–1.36) | 0.34 |
| 3 | 318 | 6 | 1.57 (0.38–6.45) | 0.53 | 277 |
| 0.01 | 430 | 178 | 0.94 (0.73–1.22) | 0.66 | 471 | 19 | 1.01 (0.52–1.94) | 0.98 |
| ≥4 | 92 | 4 | 2.83 (0.6–13.32) | 0.19 | 130 | 1.04 (0.75–1.44) | 0.80 | 138 | 78 | 1.20 (0.85–1.68) | 0.30 | 181 | 6 | 0.72 (0.28–1.85) | 0.49 |
| Total | 1,420 | 26 | 1,417 | 2,046 | 822 | 2,290 | 78 | ||||||||
Bold type: 95% CI does not include 1.00. The ORs were adjusted for:
1. Age at diagnosis, region, and occupation.
2. Age at diagnosis, region, occupation, and parity.
Carcinoma in situ.
The number of cases for T2 (N = 1,106), T3 (236), and T4 (75).
Odds ratios (ORs) for TNM classes in premenopausal ductal carcinoma by reproductive factors.
| Reproductive factors | T1 | Tis | T2–T4 | N0 | N1–N3 vr. N0 | M0 | M1 vr. M0 | |||||||||
| N | N | OR (95%CI) | P | N | OR (95%CI) | P | N | N | OR (95%CI) | P | N | N | OR (95%CI) | P | ||
|
| ||||||||||||||||
| 1 (Ref.) | 280 | 5 | 1.00 | 207 | 1.00 | 330 | 174 | 1.00 | 392 | 8 | 1.00 | |||||
| 0 | 235 | 8 | 1.79 (0.57–5.59) | 0.32 | 252 |
| –0.01 | 343 | 180 | 0.99 (0.76–1.28) | 0.93 | 408 | 14 | 1.67 (0.69–4.04) | 0.26 | |
| 2 | 830 | 24 | 1.67 (0.63–4.45) | 0.30 | 528 | 0.86 (0.70–1.06) | 0.16 | 949 | 481 | 0.97 (0.78–1.20) | 0.76 | 1,079 | 33 | 1.46 (0.67–3.19) | 0.35 | |
| 3 | 358 | 8 | 1.39 (0.45–4.36) | 0.57 | 245 | 0.94 (0.73–1.20) | 0.59 | 393 | 235 | 1.14 (0.89–1.46) | 0.30 | 488 | 8 | 0.77 (0.28–2.09) | 0.61 | |
| ≥4 | 100 | 2 | 1.33 (0.25–7.11) | 0.74 | 56 | 0.77 (0.53–1.13) | 0.18 | 108 | 58 | 1.04 (0.72–1.52) | 0.83 | 131 | 2 | 0.75 (0.15–3.62) | 0.72 | |
| Total | 1,803 | 47 | 1,288 | 2,123 | 1,128 | 2,498 | 65 | |||||||||
Bold type: 95% CI does not include 1.00. The ORs were adjusted for:
1. Age at diagnosis, region, and occupation.
2. Age at diagnosis, region, occupation, and parity.
Carcinoma in situ.
The number of cases for T2 (N = 1,047), T3 (176), and T4 (65).